Video-assisted mediastinoscopic lymphadenectomy

Area of Science:

• Thoracic Surgery
• Surgical Oncology
• Minimally Invasive Procedures

Background:

• Mediastinal lymphadenectomy is vital for accurate lung cancer staging and survival.
• Neoadjuvant therapy for stage III lung carcinoma increases the importance of pre-treatment mediastinal staging.

Purpose of the Study:

• To evaluate the efficacy and accuracy of Video-assisted mediastinoscopic lymphadenectomy (VAMLA) as a minimally invasive technique for systematic mediastinal dissection.
• To compare VAMLA with traditional open lymphadenectomy in terms of radicality, node yield, and clinical utility.

Main Methods:

• VAMLA involves systematic mediastinal dissection of anatomical structures, including stations 7, 4R+L, 2R+L, and 3.
• Data collected on dissection rates, operative time, complication rates, and accuracy (sensitivity, specificity, false negative rate) in 130 patients.

Main Results:

• VAMLA achieved high dissection rates across targeted mediastinal stations (e.g., 96% for 2R, 100% for 7).
• Mean operative duration was 54 minutes with a low complication rate of 4.6%.
• Accuracy in patients with radiologically normal mediastinum was high: 93.8% sensitivity, 100% specificity, and 0.9% false negative rate.

Conclusions:

• VAMLA is a highly accurate staging tool and a definitive surgical option for mediastinal staging.
• VAMLA is valuable for neoadjuvant therapy planning, defining radiation fields, and improving mediastinal dissection during VATS lobectomy, especially for left-sided tumors.